Address
NCI Cancer Hospital
PT 13717, Jalan BBN 2/1
71800 Nilai,
Negeri Sembilan
Darul Khusus
Malaysia
Contact
Tel: +606-850 0999
Fax:
+606-850 0733
Visiting hours:
Mon - Sun: 9am- 9pm
Outpatient hours:
Mon - Fri: 9am - 5pm
Sat: 9am - 1pm
View location map
|
|

In Malaysia , NCI Cancer Hospital (formerly known as Nilai Cancer Institute) is the pioneer private specialist center in Malaysia specializing in both cancer treatment and clinical research. NCICH clinical research complies with the international Good Clinical Practice (GCP) guidelines to ensure rights and safety of patients are protected, and the data is accurate and verifiable.
NCI clinical research complies with the international Good Clinical Practice (GCP) guidelines to ensure rights and safety of patients are protected, and the data is accurate and verifiable. NCI Cancer Hospital was also awarded the MS ISO 9001 : 2000 in 2002.
NCICH provides a warm, personal and caring environment because it is staffed
with friendly and dedicated professionals. At NCICH, we understand the needs of our patients, and their family members, and aim to provide high quality medical care with a personal touch.
NCICH is recognised internationally as a centre for conducting randomised clinical trials by multinational pharmaceutical companies.
| Dato' Dr J.C. Mehta joins NCI |
NCI Cancer Hospital has announced the appointment of
Dato' Dr. J.C. Mehta as its new Medical Director beginning 1 October 2007. Dr. Mehta is a highly respected clinician and brings to NCI Cancer Hospital 48 years of experience in the medical profession, having held various top posts throughout his career as a medical practitioner in the country.
As NCI's Medical Director, his role is to lead the senior management team in driving NCI Cancer Hospital towards excellence in both patient care and performance regionally.
His scope of responsibilities are to improve service quality, compliance with ISO 9001 standards and to progressively move the hospital towards achieving the Joint Commission International (JCI) accreditation.
Press Release
pictured above
from L to R: NCI Chairman
Datuk Dr Kim Tan;
NCI Head of Oncology & Radiation Therapy, Head of Clinical Research
Dr G Selvaratnam; NCI Medical Director
Dato' Dr J.C. Mehta
“The NCI Cancer Hospital is the only dedicated cancer centre in the country.
It has the distinction of being the first facility in Southeast Asia to introduce the Trilogy System to cater to the needs of patients requiring high-end precision radiotherapy. We have a team of highly experienced doctors and staff fully committed to serving the needs of our patients. Although our main thrust is in the treatment of cancer, we are actively involved in clinical trials with
international organisations.
As part of our expansion programme we now have a clinic in the HSC Medical Centre in the heart of Kuala Lumpur , and to participate in the much talked about medical tourism industry.
I am pleased to be a member of this dynamic team and
look forward to the exciting years ahead.”
~ Dato' Dr. J.C. Mehta ~
Medical Director
NCI Cancer Hospital
|
|
| NCI Through the Years: MILESTONES |
|
| 1999 |
Conventional Radiotherapy |
|
|
| 2000 Jan |
Commenced full operations as outpatient clinic |
|
|
2001
2001 Apr |
Accorded Good Clinical Practice (GCP) Standard
Commenced Clinical Trials
3D Conformal Radiotherapy
Introduced Brachytherapy |
|
|
| 2005 Dec |
Completion of Phase I Expansion |
|
|
|
Clinical Trials
New developments in cancer research are constantly being made. At NCICH, we offer our patients the rare opportunity to participate in clinical trials using new drugs under trials.
Find out more about our studies that are currently recruiting patients |
|
|
"The accuracy of precision radiotherapy using the Trilogy has given us the confidence to boost tumor doses while reducing the dose to surrounding healthy tissue and critical organs.
The Trilogy enables our team to handle more complicated and challenging cases while reducing the side effects suffered by our patients thus giving them a better quality of life."
M. Kala Krishnan
Senior Medical Physicist
|
|
PRECISION RADIOTHERAPY
@ NCI Cancer Hospital
The Trilogy System at NCI Cancer Hospital opens a new chapter in the radiation therapy success story of increasing cancer survival rates. As rapidly improving diagnostic techniques detect cancers earlier, Trilogy makes radiation therapy viable at earlier stages and for more types of disease. Optimized for delivering higher doses to smaller areas over shorter time periods, the Trilogy system represents significant progress toward turning cancer from a terminal disease into a chronic, manageable condition.
|
With one versatile Trilogy system, treatment facilities can deliver the full spectrum of external beam therapies:
- 3D conformal radiation therapy
- Intensity-modulated radiation therapy
- Electron therapy
- Conformal arc therapy
- Gated radiotherapy
- Image-guided radiation therapy
- Single-session or fractionated stereotactic radiosurgery
- Intensity-modulated radiosurgery
Find out more about the Trilogy |
Download Trilogy Brochure |
|

|
|
|